Weight change and long-term cardiovascular outcomes in overweight and obese patients after acute coronary syndromes
Open Access
- 18 May 2026
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal Open
- Vol. 6 (3)
Abstract
Aims: Overweight and obesity are common among patients with acute coronary syndromes (ACS), yet the long-term cardiovascular consequences of post-ACS weight change remain uncertain. We investigated the association between 1-year weight change after ACS and 5-year clinical outcomes in overweight and obese patients. Methods and results: We analysed 1473 overweight and obese ACS participants from the Swiss ELIPS cohort with available weight measurements. Hazard ratios (HRs) were estimated per 1% and 5% weight change for the 5-year risk of major adverse cardiovascular events (MACE), defined as cardiovascular death, non-fatal myocardial infarction, coronary revascularization, stroke, or transient ischaemic attack. Models were adjusted for age, sex, body mass index (BMI), smoking, total cholesterol, hypertension, diabetes, and estimated glomerular filtration rate. Predefined subgroups included BMI ≥ 27 kg/m2 vs. 25–27 kg/m2. Among the participants (15.1% women, mean age 61.5 years), the median BMI was 28.1 kg/m2 (67% BMI ≥ 27 kg/m2). Median 1-year weight change was 0%; 47.5% lost weight and 18.7% achieved >5% weight loss. Patient characteristics associated with weight loss were older age, higher BMI, non-smoking status, and participation in cardiac rehabilitation. During follow-up, 278 MACE events occurred. Weight loss was associated with a lower risk of MACE [multivariate-adjusted HR per 5%: 0.90, 95% confidence interval (CI): 0.82–1.00, P = 0.04]. The association was stronger in patients with BMI ≥ 27 kg/m2 (adj HR per 5% 0.87, 95% CI: 0.77–0.97) compared to those with BMI 25–27 kg/m2 (adj HR per 5% 1.01, 95% CI: 0.85–1.20, interaction P = 0.16). Conclusion: Overweight and obese ACS patients who lose weight may have a lower risk of cardiovascular events.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (33CM30-124112)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (33CM30-140336)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (32003B_207881)
This publication has 53 references indexed in Scilit:
- Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trialThe Lancet, 2025
- The role of cardiac rehabilitation in improving cardiovascular outcomesNature Reviews Cardiology, 2021
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood CholesterolJACC, 2019
- Weight loss is a critical factor to reduce inflammationClinical Nutrition ESPEN, 2018
- Effects on cardiovascular risk factors of weight losses limited to 5–10 %Translational Behavioral Medicine, 2015
- Alcohol Consumption and Obesity: An UpdateCurrent Obesity Reports, 2015
- The obesity paradox in acute coronary syndrome: a meta-analysisEuropean Journal of Epidemiology, 2014
- Obesity and Cardiovascular DiseasesJACC, 2014
- Obesity and Cardiovascular DiseaseJACC, 2009
- Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studiesThe Lancet, 2006